Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Glioblastoma in natalizumab-treated multiple sclerosis patients.
Sierra Morales F, Wright RB, Novo JE, Arvanitis LD, Stefoski D, Koralnik IJ. Sierra Morales F, et al. Among authors: stefoski d. Ann Clin Transl Neurol. 2017 Jun 6;4(7):512-516. doi: 10.1002/acn3.428. eCollection 2017 Jul. Ann Clin Transl Neurol. 2017. PMID: 28695151 Free PMC article.
Treatment of natalizumab-associated PML with filgrastim.
Stefoski D, Balabanov R, Waheed R, Ko M, Koralnik IJ, Sierra Morales F. Stefoski D, et al. Ann Clin Transl Neurol. 2019 Apr 8;6(5):923-931. doi: 10.1002/acn3.776. eCollection 2019 May. Ann Clin Transl Neurol. 2019. PMID: 31139690 Free PMC article.
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial.
Giovannoni G, Gold R, Selmaj K, Havrdova E, Montalban X, Radue EW, Stefoski D, McNeill M, Amaravadi L, Sweetser M, Elkins J, O'Neill G; SELECTION Study Investigators. Giovannoni G, et al. Among authors: stefoski d. Lancet Neurol. 2014 May;13(5):472-81. doi: 10.1016/S1474-4422(14)70039-0. Epub 2014 Mar 19. Lancet Neurol. 2014. PMID: 24656609 Clinical Trial.
55 results